Moderna Inc (MRNA) - Financial and Strategic SWOT Analysis Review
Section 1 - About the Company
Moderna Inc - Key Facts
Moderna Inc - Key Employees
Moderna Inc - Key Employee Biographies
Moderna Inc - Major Products and Services
Moderna Inc - History
Moderna Inc - Company Statement
Moderna Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Moderna Inc - Business Description
Other Break-up: Collaboration Revenue
Performance
Other Break-up: Grant Revenue
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
Moderna Inc - Corporate Strategy
Moderna Inc - SWOT Analysis
SWOT Analysis - Overview
Moderna Inc - Strengths
Moderna Inc - Weaknesses
Moderna Inc - Opportunities
Moderna Inc - Threats
Moderna Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Moderna Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Moderna Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Moderna Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 07, 2024: Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates
Oct 21, 2024: Northwestern University Files Patent Infringement Lawsuit Against Moderna Over mRNA Vaccine Technologies
Oct 02, 2024: Moderna Adds Abbas Hussain to Board of Directors
Sep 12, 2024: Moderna Announces R&D Progress and Strategic Priorities
Sep 09, 2024: Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada
Aug 30, 2024: Albertsons Companies Pharmacies Announce COVID and Flu Vaccines Available Now to Help Protect Communities Against the Upcoming Respiratory Virus Season
Aug 22, 2024: FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants
Aug 01, 2024: Moderna Posts Q2 2024 Financial Results
Jul 23, 2024: Moderna Appoints David Rubenstein to Board of Directors
May 13, 2024: Moderna to Present at Upcoming Conferences in May/June 2024
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Moderna Inc, Key Facts
Moderna Inc, Key Employees
Moderna Inc, Key Employee Biographies
Moderna Inc, Major Products and Services
Moderna Inc, History
Moderna Inc, Subsidiaries
Moderna Inc, Key Competitors
Moderna Inc, Ratios based on current share price
Moderna Inc, Annual Ratios
Moderna Inc, Annual Ratios (Cont...1)
Moderna Inc, Annual Ratios (Cont...2)
Moderna Inc, Interim Ratios
Moderna Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Moderna Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Moderna Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Moderna Inc, Performance Chart (2019 - 2023)
Moderna Inc, Ratio Charts
Moderna Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Moderna Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024